Other next-generation sequence studies by Xu et al. and Chapugy et al. have recently demonstrated similar frequencies of mutated MYD88 (15–18%) in large cohorts of DLBCL [12, 15]. The gene discussed is MYD88; the disease is diffuse large B-cell lymphoma.